Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Sirtris Pharmaceuticals gets $13mm with Series A round
03 Jan 2005
Sirtris Pharmaceuticals (focused on developing drug candidates that target class III histone deacetylases--HDACs--or sirtuins) raised $13mm with its Series A financing led by new investor Wellcome Trust. Returning shareholders Polaris Venture Partners, Techno Venture Management, Cardinal Partners, and Skyline Ventures co-led the round.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?